Heather Mason
Chief Executive Officer at ASSERTIO HOLDINGS, INC.
Net worth: 695 083 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Ford | M | 50 |
Abbott Diabetes Care, Inc.
 Abbott Diabetes Care, Inc. Medical SpecialtiesHealth Technology Abbott Diabetes Care, Inc. manufactures glucose monitoring equipments. It designs, develops and manufactures glucose monitoring systems and test strips for use in both home and hospital settings. The company was founded on August 29, 2005 and is headquartered in Abbott Park, IL. | 10 years |
| Harpreet Singh-Jasuja | M | 50 |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 24 years |
| Steffen Walter | M | 47 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 9 years |
| John Eid | M | - |
Pendulum Therapeutics, Inc.
 Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | 12 years |
| Peter Staple | M | 72 | 21 years | |
| Toni Weinschenk | M | 51 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 9 years |
| Colleen Cutcliffe | M | - |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | 12 years |
| Karim Bitar | M | 59 | 5 years | |
| Rainer Kramer | M | 60 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 12 years |
| Kimberly Lody | F | 58 | 2 years | |
| Jonathan Mason | M | 60 | 2 years | |
| Michael Atieh | M | 70 | 4 years | |
| James Bullard | M | - |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | 12 years |
| Jeffrey Vacirca | M | 55 | 1 years | |
| Carsten Reinhardt | M | 57 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 4 years |
| Paul Schwichtenberg | M | 53 | 6 years | |
| Ajay Patel | M | 40 | 5 years | |
| Evelyn Douglas | F | - | 4 years | |
| Christof Hettich | M | 64 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 16 years |
| Constantin Coussios | M | - | 4 years | |
| Brian May | M | 60 | 4 years | |
| William McKee | M | 62 | 7 years | |
| Paul Carter | M | 63 | 4 years | |
| Peter Chambré | M | 68 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 12 years |
| Friedrich von Bohlen und Halbach | M | 60 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | 3 years |
| Margaret Ewing | F | 69 | 7 years | |
| Sharon O'Keefe | F | 72 | 2 years | |
| James Tyree | M | 71 | 8 years | |
| Sam Schlessinger | M | 42 | 4 years | |
| Drew Dale | M | - |
SCA Pharmaceuticals LLC
 SCA Pharmaceuticals LLC Medical DistributorsDistribution Services SCA Pharmaceuticals LLC provides sterile admixture services and pre-filled oral syringes. It specializes in preparing sterile pharmaceuticals customized for hospitals and healthcare facilities. The firm offers outsourcing services for cardiovascular, pain management and anesthesia. The company was founded by Gene Graves and is headquartered in Little Rock, AR. | 5 years |
| Mohan S. Iyer | M | - |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | - |
| Peter Hutt | M | 89 |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | 8 years |
| Claudia Blattner | M | - | 9 years | |
| Adam Stone | M | 44 | 4 years | |
| William Iskos | M | - | 3 years | |
| Vanessa Fox | F | - | 6 years | |
| Hugh C. Martin | M | 70 |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | 11 years |
| Howard Franklin | M | - | 1 years | |
| John Haller | M | - | 2 years | |
| Scott Luce | M | - |
SCA Pharmaceuticals LLC
SCA Pharmaceuticals LLC Medical DistributorsDistribution Services SCA Pharmaceuticals LLC provides sterile admixture services and pre-filled oral syringes. It specializes in preparing sterile pharmaceuticals customized for hospitals and healthcare facilities. The firm offers outsourcing services for cardiovascular, pain management and anesthesia. The company was founded by Gene Graves and is headquartered in Little Rock, AR. | - |
| Ephraim Hofsäß | M | - | 5 years | |
| Maria Poulada | F | - | 11 years | |
| Miriam Meyer | M | - | 15 years | |
| Cedrik M. Britten | M | 49 | 4 years | |
| Winfred Parnell | M | 71 |
SCA Pharmaceuticals LLC
SCA Pharmaceuticals LLC Medical DistributorsDistribution Services SCA Pharmaceuticals LLC provides sterile admixture services and pre-filled oral syringes. It specializes in preparing sterile pharmaceuticals customized for hospitals and healthcare facilities. The firm offers outsourcing services for cardiovascular, pain management and anesthesia. The company was founded by Gene Graves and is headquartered in Little Rock, AR. | - |
| Edward Sturchio | M | - | 4 years | |
| Harald F. Stock | M | 56 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | - |
| Matthias Kromayer | M | 58 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | - |
| Arnd Christ | M | 57 | 4 years | |
| Eliot Forster | M | 58 | 4 years | |
| Kate Postans | F | - | - | |
| Jordan Silverstein | M | - | 5 years | |
| Erich Schlick | M | 72 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | - |
| Kjersti Grimsrud | F | 63 | 6 years | |
| Sravan Emany | M | 46 | 1 years | |
| Adam D’Augelli | M | - |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | 11 years |
| Divakar Ramakrishnan | M | - | 4 years | |
| Mathias Hothum | M | 58 | 1 years | |
| Roelof Botha | M | 50 |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | 5 years |
| John McAdam | M | 76 | 5 years | |
| Ryan Glaws | M | - |
SCA Pharmaceuticals LLC
SCA Pharmaceuticals LLC Medical DistributorsDistribution Services SCA Pharmaceuticals LLC provides sterile admixture services and pre-filled oral syringes. It specializes in preparing sterile pharmaceuticals customized for hospitals and healthcare facilities. The firm offers outsourcing services for cardiovascular, pain management and anesthesia. The company was founded by Gene Graves and is headquartered in Little Rock, AR. | - |
| Tamara Louw | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Peisert | M | 49 | - | |
| Rick Anderson | M | 63 | 6 years | |
| Todd Smith | M | 55 | - | |
| Donal Balfe | M | - | 5 years | |
| Scott Salys | M | - | 4 years | |
| Timothy Walbert | M | 57 | - | |
| Megan Timmins | F | 51 | - | |
| Peter J. Devlin | M | 56 |
Abbott Diabetes Care, Inc.
Abbott Diabetes Care, Inc. Medical SpecialtiesHealth Technology Abbott Diabetes Care, Inc. manufactures glucose monitoring equipments. It designs, develops and manufactures glucose monitoring systems and test strips for use in both home and hospital settings. The company was founded on August 29, 2005 and is headquartered in Abbott Park, IL. | 11 years |
| Robert Steele | M | - | 6 years | |
| Max Nemmers | M | - | - | |
| John Magnus Lindskog | M | - | 12 years | |
| Rosalind Rivaz | M | 68 | 3 years | |
| Regina Benjamin | M | 67 | 5 years | |
| Peter Witty | M | 56 | 10 years | |
| Brian L. Durkin | M | 63 | 30 years | |
| Jane J. Song | F | 61 | 17 years | |
| Molly D. VandenHeuvel | F | 54 | 4 years | |
| Marcus Schulz | M | 46 | 2 years | |
| Sharon Larkin | F | 60 | 23 years | |
| John Hernandez | M | 57 | 6 years | |
| Melanie Gloria | F | - | 5 years | |
| Robert Edesses | M | - | 1 years | |
| Joseph Holmes | M | 45 | - | |
| Clare Bates | F | 48 | 5 years | |
| Anat Hakim | F | 54 | 6 years | |
| Quincy Troupe | M | 58 |
Abbott Laboratories, Inc.
 Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the private company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 3 years |
| Geoffrey M. Curtis | M | 49 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the private company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 2 years |
| Valentine Yien | F | 71 | 5 years | |
| Philip Ebeling | M | 54 | 1 years | |
| Katherine Doyle | F | 56 |
Abbott Nutrition Manufacturing, Inc.
 Abbott Nutrition Manufacturing, Inc. Pharmaceuticals: OtherHealth Technology Abbott Nutrition Manufacturing, Inc. manufactures, markets, and distributes adult and pediatric products. Its brand offerings include Similac for infant formulas, PediaSure to help kids grow, Pedialyte hydration for kids and adults, Ensure for active adults, ZonePerfect, EAS for elite athletes and fitness enthusiasts, and Glucerna for people with diabetes. The company was founded in 1903 and is headquartered in Columbus, OH. | 3 years |
| Stuart Paul | M | 64 | 1 years | |
| Candace Steele Flippin | F | - | 1 years | |
| Chris D. Emery | M | - | 3 years | |
| Mark John Alexander Webster | M | 62 |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the private company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 2 years |
| Preston T. Simons | M | - | 15 years | |
| Eric Fain | M | 63 | - | |
| John C. Landgraf | M | 71 | 38 years | |
| Li Chen | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 66 | 66.00% |
| Germany | 22 | 22.00% |
| United Kingdom | 20 | 20.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Heather Mason
- Personal Network